| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GATA binding protein 1 | 0.483 | 0.808 | 0.95 |
|
disease | 0.500 | None | 0.955 | 66 | 0 | 2002 | 2018 | ||||||||
|
Janus kinase 3 | 0.505 | 0.731 | 5.9E-06 |
|
disease | 0.460 | None | 1.000 | 5 | 3 | 2006 | 2011 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.120 | None | 1.000 | 2 | 4 | 2000 | 2012 | ||||||||
|
myocardin related transcription factor A | 0.572 | 0.615 | 1.00 |
|
disease | 0.100 | None | 1.000 | 36 | 0 | 2001 | 2020 | ||||||||
|
serum response factor | 0.534 | 0.808 | 0.98 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2006 | 2019 | ||||||||
|
RNA binding motif protein 15 | 0.736 | 0.154 | 0.99 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2001 | 2018 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2004 | 2018 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2013 | 2019 | ||||||||
|
interleukin 3 | 0.489 | 0.731 | 2.6E-09 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1992 | 2007 | ||||||||
|
GLIS family zinc finger 2 | 0.608 | 0.462 | 0.86 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2012 | 2020 | ||||||||
|
mal, T cell differentiation protein | 0.570 | 0.577 | 0.83 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2004 | 2015 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
disease | 0.050 | None | 1.000 | 5 | 1 | 2005 | 2019 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2016 | ||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 1989 | 2006 | ||||||||
|
CBFA2/RUNX1 partner transcriptional co-repressor 3 | 0.638 | 0.462 | 4.8E-02 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2013 | 2020 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1992 | 1994 | ||||||||
|
myeloperoxidase | 0.377 | 0.923 | 7.1E-15 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1989 | 1990 | ||||||||
|
ETS transcription factor ERG | 0.453 | 0.808 | 0.96 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2011 | 2015 | ||||||||
|
nucleoporin 98 and 96 precursor | 0.532 | 0.577 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 2013 | 2019 | ||||||||
|
cytidine/uridine monophosphate kinase 1 | 0.626 | 0.577 | 0.85 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1992 | 2007 | ||||||||
|
C-X-C motif chemokine ligand 9 | 0.462 | 0.808 | 2.9E-03 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1992 | 2007 | ||||||||
|
glycoprotein Ib platelet subunit alpha | 0.565 | 0.692 | 3.2E-03 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2005 | ||||||||
|
platelet factor 4 | 0.522 | 0.846 | 4.3E-02 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1991 | 1991 | ||||||||
|
immunoglobulin heavy variable 1-12 (pseudogene) | 0.569 | 0.654 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2014 | |||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2012 |